Breslin & Breslin, P.A. Breslin & Breslin, P.A.
201-546-5881 866-986-2056
Call Today

Contact Our Firm To Discuss Your Medical Malpractice Legal Concerns

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Take Action Now - Call 201-546-5881

In the wake of national meningitis outbreak: a rising human toll

By way of an update, which is perhaps timely given a batch of relevant numbers just reported in the Boston Globe, we seek to keep our New Jersey and other readers abreast of material developments in the nation’s unprecedented meningitis outbreak that occurred in 2012.

As many readers already know, that story was far from a self-contained tale of limited duration. Rather, deaths and injuries in the case, which involved contaminated injections manufactured and distributed by a Massachusetts pharmacy, continue to mount even now.

That pharmacy, the New England Compounding Center, is one of a comparatively few such entities across the country that fills a void by making specialized drugs in small quantities for select patients. Unfortunately, things at the NECC got out of hand, and large quantities of a steroid drug were distributed to scores of medical centers across the country, including in New Jersey (NECC declared bankruptcy last year and is no longer in business).

Tragically, the vials those drugs were contained in were tainted, and the numbers of dead and injured parties across the country began to soar. Current estimates list 64 people dead from the contaminated injections, with another 750 or so having meningitis-linked maladies. Many others from among the estimated 14,000 people who received shots have also reported adverse side effects.

Litigation in the matter has understandably escalated, with lawsuits targeting both NECC on grounds of product liability and scores of medical providers for alleged medical malpractice in failing to adequately investigate NECC or do requisite quality control checks on the vials of steroids.

The Globe states that more than 600 claims have been initiated against just NECC, with many of those lawsuits now consolidated before one federal court in multidistrict litigation.

Sadly, the human costs will likely continue to rise, given the number of victims who continue to add to the list of injury complaints.

Source: Boston Globe, "Victims of tainted drug face long wait for relief," Todd Wallack, Oct. 2, 2013

No Comments

Leave a comment
Comment Information

$7.4 Billion Medicaid Recovery

Breslin and Breslin, PA, Donald A. Caminiti, Esq., was one of six law firms selected by the Attorney General of the State of New Jersey to act as special counsel to represent it in its lawsuit against the tobacco industry to recover Medicaid and other health related costs incurred by the state resulting from tobacco related illnesses.